Skip to main content
Intermediate Technical IVT

estrogen receptor positive

Breast cancer cells that have estrogen receptors and typically respond to hormone-blocking treatments.

Full Definition

Estrogen receptor positive (ER+) breast cancer refers to tumors where at least 1% of cancer cells have estrogen receptors that can bind to the hormone estrogen. These receptors can stimulate cancer cell growth when estrogen is present. ER+ status is determined through immunohistochemistry testing and is crucial for treatment planning, as these cancers typically respond well to hormone therapy such as tamoxifen or aromatase inhibitors. Approximately 70-80% of breast cancers are ER+.

Usage

Usage note: Use ER+ abbreviation only after first mention of full term in document.

In Context

  • "The tumor was estrogen receptor positive with 85% nuclear staining intensity." — Pathology report
  • "Patients with estrogen receptor positive tumors are candidates for adjuvant endocrine therapy." — Treatment guideline

Also known as

ER+ ER-positive hormone receptor positive

Contrasted with

estrogen receptor negative ER-negative

Don't confuse with

progesterone receptor positive HER2-positive

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON